159 related articles for article (PubMed ID: 23713488)
21. PG12, a phospholipid analog with potent antimalarial activity, inhibits Plasmodium falciparum CTP:phosphocholine cytidylyltransferase activity.
González-Bulnes P; Bobenchik AM; Augagneur Y; Cerdan R; Vial HJ; Llebaria A; Ben Mamoun C
J Biol Chem; 2011 Aug; 286(33):28940-28947. PubMed ID: 21705805
[TBL] [Abstract][Full Text] [Related]
22. Structural basis for the inhibition of the essential Plasmodium falciparum M1 neutral aminopeptidase.
McGowan S; Porter CJ; Lowther J; Stack CM; Golding SJ; Skinner-Adams TS; Trenholme KR; Teuscher F; Donnelly SM; Grembecka J; Mucha A; Kafarski P; Degori R; Buckle AM; Gardiner DL; Whisstock JC; Dalton JP
Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2537-42. PubMed ID: 19196988
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of brequinar analogue inhibitors of malaria parasite dihydroorotate dehydrogenase.
Boa AN; Canavan SP; Hirst PR; Ramsey C; Stead AM; McConkey GA
Bioorg Med Chem; 2005 Mar; 13(6):1945-67. PubMed ID: 15727850
[TBL] [Abstract][Full Text] [Related]
24. Plasmodium falciparum neutral aminopeptidases: new targets for anti-malarials.
Skinner-Adams TS; Stack CM; Trenholme KR; Brown CL; Grembecka J; Lowther J; Mucha A; Drag M; Kafarski P; McGowan S; Whisstock JC; Gardiner DL; Dalton JP
Trends Biochem Sci; 2010 Jan; 35(1):53-61. PubMed ID: 19796954
[TBL] [Abstract][Full Text] [Related]
25. Modelling of human leucyl aminopeptidases for in silico off target binding analysis of potential Plasmodium falciparum leucine aminopeptidase (PfA-M17) specific inhibitors.
Sahi S; Raj U; Chaudhary M; Nain V
Recent Pat Endocr Metab Immune Drug Discov; 2014; 8(3):191-201. PubMed ID: 25269653
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of branched 9-[2-(2-phosphonoethoxy)ethyl]purines as a new class of acyclic nucleoside phosphonates which inhibit Plasmodium falciparum hypoxanthine-guanine-xanthine phosphoribosyltransferase.
Hocková D; Holý A; Masojídková M; Keough DT; de Jersey J; Guddat LW
Bioorg Med Chem; 2009 Sep; 17(17):6218-32. PubMed ID: 19666228
[TBL] [Abstract][Full Text] [Related]
27. A structural insight into the P1S1 binding mode of diaminoethylphosphonic and phosphinic acids, selective inhibitors of alanine aminopeptidases.
Węglarz-Tomczak E; Berlicki Ł; Pawełczak M; Nocek B; Joachimiak A; Mucha A
Eur J Med Chem; 2016 Jul; 117():187-96. PubMed ID: 27100031
[TBL] [Abstract][Full Text] [Related]
28. Diastereoselective functionalizations of enecarbamates derived from pipecolic acid towards 5-guanidinopipecolates as arginine mimetics.
Le Corre L; Kizirian JC; Levraud C; Boucher JL; Bonnet V; Dhimane H
Org Biomol Chem; 2008 Sep; 6(18):3388-98. PubMed ID: 18802647
[TBL] [Abstract][Full Text] [Related]
29. Mapping the substrate specificity of the Plasmodium M1 and M17 aminopeptidases.
Malcolm TR; Swiderska KW; Hayes BK; Webb CT; Drag M; Drinkwater N; McGowan S
Biochem J; 2021 Jul; 478(13):2697-2713. PubMed ID: 34133730
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological evaluation of nucleoside dicarboxylates as potential mimics of nucleoside diphosphates.
Boudreau MA; Vederas JC
Org Biomol Chem; 2007 Feb; 5(4):627-35. PubMed ID: 17285171
[TBL] [Abstract][Full Text] [Related]
31. X-ray crystal structure and specificity of the Plasmodium falciparum malaria aminopeptidase PfM18AAP.
Sivaraman KK; Oellig CA; Huynh K; Atkinson SC; Poreba M; Perugini MA; Trenholme KR; Gardiner DL; Salvesen G; Drag M; Dalton JP; Whisstock JC; McGowan S
J Mol Biol; 2012 Sep; 422(4):495-507. PubMed ID: 22709581
[TBL] [Abstract][Full Text] [Related]
32. Identification of phosphinate dipeptide analog inhibitors directed against the Plasmodium falciparum M17 leucine aminopeptidase as lead antimalarial compounds.
Skinner-Adams TS; Lowther J; Teuscher F; Stack CM; Grembecka J; Mucha A; Kafarski P; Trenholme KR; Dalton JP; Gardiner DL
J Med Chem; 2007 Nov; 50(24):6024-31. PubMed ID: 17960925
[TBL] [Abstract][Full Text] [Related]
33. Crystal structure of S-adenosyl-L-homocysteine hydrolase from the human malaria parasite Plasmodium falciparum.
Tanaka N; Nakanishi M; Kusakabe Y; Shiraiwa K; Yabe S; Ito Y; Kitade Y; Nakamura KT
J Mol Biol; 2004 Oct; 343(4):1007-17. PubMed ID: 15476817
[TBL] [Abstract][Full Text] [Related]
34. Chemical target validation studies of aminopeptidase in malaria parasites using alpha-aminoalkylphosphonate and phosphonopeptide inhibitors.
Cunningham E; Drag M; Kafarski P; Bell A
Antimicrob Agents Chemother; 2008 Sep; 52(9):3221-8. PubMed ID: 18458130
[TBL] [Abstract][Full Text] [Related]
35. Plasmodium falciparum: new molecular targets with potential for antimalarial drug development.
Gardiner DL; Skinner-Adams TS; Brown CL; Andrews KT; Stack CM; McCarthy JS; Dalton JP; Trenholme KR
Expert Rev Anti Infect Ther; 2009 Nov; 7(9):1087-98. PubMed ID: 19883329
[TBL] [Abstract][Full Text] [Related]
36. Development of benzophenone-based farnesyltransferase inhibitors as novel antimalarials.
Kohring K; Wiesner J; Altenkämper M; Sakowski J; Silber K; Hillebrecht A; Haebel P; Dahse HM; Ortmann R; Jomaa H; Klebe G; Schlitzer M
ChemMedChem; 2008 Aug; 3(8):1217-31. PubMed ID: 18470859
[TBL] [Abstract][Full Text] [Related]
37. Fingerprinting the substrate specificity of M1 and M17 aminopeptidases of human malaria, Plasmodium falciparum.
Poreba M; McGowan S; Skinner-Adams TS; Trenholme KR; Gardiner DL; Whisstock JC; To J; Salvesen GS; Dalton JP; Drag M
PLoS One; 2012; 7(2):e31938. PubMed ID: 22359643
[TBL] [Abstract][Full Text] [Related]
38. M17 leucine aminopeptidase of the human malaria parasite Plasmodium vivax.
Lee JY; Song SM; Seok JW; Jha BK; Han ET; Song HO; Yu HS; Hong Y; Kong HH; Chung DI
Mol Biochem Parasitol; 2010 Mar; 170(1):45-8. PubMed ID: 19931315
[TBL] [Abstract][Full Text] [Related]
39. Plasmodium falciparum glyoxalase II: Theorell-Chance product inhibition patterns, rate-limiting substrate binding via Arg(257)/Lys(260), and unmasking of acid-base catalysis.
Urscher M; Deponte M
Biol Chem; 2009 Nov; 390(11):1171-83. PubMed ID: 19663684
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of hypoxanthine-guanine phosphoribosyltransferase by acyclic nucleoside phosphonates: a new class of antimalarial therapeutics.
Keough DT; Hocková D; Holý A; Naesens LM; Skinner-Adams TS; Jersey Jd; Guddat LW
J Med Chem; 2009 Jul; 52(14):4391-9. PubMed ID: 19527031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
